Research and development for botanical products in medicinals and food supplements market

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Miroddi, Marco ^a   Mannucci, Carmen ^a   Mancari, Ferdinando ^a   Navarra, Michele ^b   Calapai, Gioacchino ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT;

DIET SUPPLEMENTATION; EUROPE; HERBAL MEDICINE; LAW; NONHUMAN; NUTRITION; PLANT PRODUCT; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; UNITED STATES;

EID: 84876564730     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/649720     Document Type: Review

References (33)

1. Coppens P., Delmulle L., Gulati O., Richardson D., Ruthsatz M., Sievers H., Sidani S., Use of botanicals in food supplements: regulatory scope, scientific risk assessment and claim substantiation. Annals of Nutrition and Metabolism 2006 50 6 538 554 2-s2.0-33846891101 10.1159/000098146 (Pubitemid 46218888)
2. Knöss W., Chinou I., Regulation of medicinal plants for public health-european community monographs on herbal substances. Planta Medica 2012 78 12 1311 1316
3. Ajazuddin, Saraf S., Legal regulations of complementary and alternative medicines in different countries. Pharmacognosy Reviews 2012 6 12 154 160
4. Silano V., Coppens P., Larranaga-Guetaria A., Minghetti P., Roth-Ehrang R., Regulations applicable to plant food supplements and related products in the European Union. Food & Function 2011 2 12 710 719
5. Directive 2004/24/EEC of the European parliament and of the council of 31 March 2004 amending, as regards traditional herbal medicinal products, directive 2001/83/EC on community code relating to medicinal products for human use. Official Journal of the European Communities 2004 L136 85 90
6. Directive 2001/83/EC of the European Parliament and ofthe Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use. http://ec.europa.eu/health/files/eudralex/vol-1/dir-2001-83/2001-83-ec-en. pdf
7. Calapai G., Caputi A. P., Herbal medicines: can we do without pharmacologist? Evidence-Based Complementary and Alternative Medicine 2007 4 1 41 43 2-s2.0-63049136875 10.1093/ecam/nem095
8. Quintus C., Schweim H. G., European regulation of herbal medicinal products on the border area to the food sector. Phytomedicine 2012 19 3-4 378 381
9. Calapai G., European legislation on herbal medicines: a look into the future. Drug Safety 2008 31 5 428 431 2-s2.0-42449162940 10.2165/00002018- 200831050-00009 (Pubitemid 351563737)
10. Guideline on the assessment of clinical safety and efficacy in the preparation of community herbal monographs for well-established and of community herbal monographs/entries to the community list for traditional herbal medicinal products/substances/preparations. http://www.ema.europa.eu/docs/en-GB/ document-library/Scientific-guideline/2009/09/WC500003644.pdf
11. Schmidt B., Ribnicky D. M., Poulev A., Logendra S., Cefalu W. T., Raskin I., A natural history of botanical therapeutics. Metabolism 2008 57 1 S3 S9 2-s2.0-44949167800 10.1016/j.metabol.2008.03.001 (Pubitemid 351814695)
12. Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Official Journal of the European Union 2006 L404 9 25
13. Butler M. S., The role of natural product chemistry in drug discovery. Journal of Natural Products 2004 67 12 2141 2153 2-s2.0-11344292132 10.1021/np040106y (Pubitemid 40092578)
14. Hasler C. M., Health claims in the United States: an aid to the public or a source of confusion? Journal of Nutrition 2008 138 6 1216S 1220S 2-s2.0-44449104205 (Pubitemid 351769154)
15. Franz C., Chizzola R., Novak J., Sponza S., Botanical species being used for manufacturing plant food supplements (PFS) and related products in the EU member states and selected third countries. Food & Function 2011 2 12 720 730
16. Regulation (EC) No. 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. Official Journal 2002 L31 1 24
17. Council directive 2002/46/EC of 10 June 2002 on the approximation of the laws of the member states relating to food supplements. Official Journal 2002 L183 51 57
18. Cassileth B. R., Heitzer M., Wesa K., The public health impact of herbs and nutritional supplements. Pharmaceutical Biology 2009 47 8 761 767 2-s2.0-77149136120 10.1080/13880200902991581
19. Nutrition Labeling and Education Act. Pub L 101-535, US Code title 104, section 2353, 1990
20. US Food and Drug Administration, Guidance for industry: significant scientific agreement in the review of health claims for conventional foods and dietary supplements. http://www.fda.gov/food/ guidancecomplianceregulatoryinformation/guidancedocuments/foodlabelingnutrition/ ucm073332.htm
21. US Food and Drug Administration, FDA Modernization Act of 1997 (FDAMA) claims. http://www.fda.gov/food/labelingnutrition/labelclaims/ fdamodernizationactfdamaclaims/default.htm
22. US Food and Drug Administration, Qualified health claims. http://www.fda.gov/food/labelingnutrition/labelclaims/qualifiedhealthclaims/
23. Ellwood K. C., Trumbo P. R., Kavanaugh C. J., How the US food and drug administration evaluates the scientific evidence for health claims. Nutrition Reviews 2010 68 2 114 121 2-s2.0-77950365975 10.1111/j.1753-4887.2009.00267.x
24. Guideline on non-clinical documentation for herbal medicinal products in applications for marketing authorisation (bibiographical and mixed applications) and in applications or simplified registration. http://www.ema.europa.eu/ema/ index.jsp?curl=pages/regulation/general/general-content-000402.jsp&mid= WC0b01ac0580029571
25. Guideline on selection of test materials for genotoxicity testing for Traditional Herbal Medicinal Products/Herbal Medicinal Products. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/ general-content-000402.jsp&mid=WC0b01ac0580029571
26. Wu K. M., Ghantous H., Birnkrant D. B., Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States. Food and Chemical Toxicology 2008 46 8 2606 2610 2-s2.0-47149089182 10.1016/j.fct.2008.05.029
27. Chen S., Dou J., Temple R., Agarwal R., Wu K. M., Walker S., New therapies from old medicines-approval of the first botanical prescription drug by FDA and the challenges of developing botanical new drugs. Nature Biotechnology 2008 26 1077 1083 10.1038/nbt1008-1077
28. Wu K. M., Dou J., Ghantous H., Chen S., Bigger A., Birnkrant D., Current regulatory perspectives on genotoxicity testing for botanical drug product development in the U.S.A. Regulatory Toxicology and Pharmacology 2010 56 1 1 3 2-s2.0-75549085963 10.1016/j.yrtph.2009.09.012
29. Rietjens I. M. C. M., Slob W., Galli C., Silano V., Risk assessment of botanicals and botanical preparations intended for use in food and food supplements: emerging issues. Toxicology Letters 2008 180 2 131 136 2-s2.0-48649110501 10.1016/j.toxlet.2008.05.024
30. van den Berg S. J., Serra-Majem L., Coppens P., Rietjens I. M., Safety assessment of plant food supplements (PFS). Food & Function 2011 2 12 760 768
31. de Lima Toccafondo Vieira M., Huang S. M., Botanical-drug interactions: a scientific perspective. Planta Medica 2012 78 13 1400 1415 10.1055/s-0032- 1315145
32. He S. M., Li C. G., Liu J. P., Chan E., Duan W., Zhou S. F., Disposition pathways and pharmacokinetics of herbal medicines in humans. Current Medicinal Chemistry 2010 17 33 4072 4113 2-s2.0-78751553732 10.2174/092986710793205336
33. Steinhoff B., Current perspectives on herb-drug interactions in the European regulatory landscape. Planta Medica 2012 78 13 1416 1420 10.1055/s-0032-1314939